Symbiosis Pharmaceutical Services, a specialist provider of pharmaceutical and vaccine development services, has announced it has signed a supply agreement with AstraZeneca for sterile manufacture of the COVID-19 recombinant adenovirus vaccine known as AZD1222 for AstraZeneca sponsored clinical trials.

A report by an independent group of experts looking at future economic growth in response to the coronavirus pandemic has been welcomed by Scottish Enterprise.

The Morvern Community Development Company (MCDC) has worked with Triodos Bank UK and the Scottish Investment Bank (SIB), the investment arm of Scottish Enterprise, to secure a new finance arrangement to support the development of a high-head (142m) hydropower scheme on the Barr River near Loch Teacuis, Morvern in Lochaber, Scotland.

• Head of John Lewis Glasgow Isabella Miller confirmed for highly-coveted role
• John Lewis Partnership is largest employee-owned business in the UK
• Scotland for Employee Ownership has aspiration of 500 employee-owned businesses by 2030

The widespread use of electric vehicles across the UK has moved a step closer following a £4.1 million funding deal to support the growth of Trojan Energy’s innovative on-street charging product.

ION Geo is a global software firm with a base in Edinburgh and has transformed manual operations at Montrose Port Authority with its Marlin™ SmartPort optimisation software and recently completed a full digital switchover.

Scottish Enterprise has welcomed the publication of EY Scotland’s Attractiveness Survey 2020 that confirms Scotland continues to be the most attractive location for inward investment in the UK outside of London.

Pneumagen (Holdings) Ltd, focused on treating infectious diseases by targeting the human glycome, today announced a GBP £4 million investment to allow the clinical development of Neumifil for the prevention and treatment of COVID-19.

MGB Biopharma, the Glasgow-based biopharmaceutical company developing a novel class of anti-infectives, today announced the successful conclusion of its Phase II clinical study into MGB-BP-3, for the treatment of Clostridium difficile Infection (CDI). The study confirms that the drug has the potential to become the new gold standard, first-line treatment for CDI.

• UK government and Honeywell sign agreement for 70 million face masks to support U.K.’s response to COVID-19 outbreak
• New production line to create approximately 450 jobs in Newhouse

Scottish Enterprise and partners today advised that from mid-morning on Thursday 14 May 2020 the Pivotal Enterprise Resilience Fund will reopen for new applications.